{"disease":{"id":"oncolytic-virotherapy","name":"oncolytic virotherapy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05376527","title":"Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"\"Oncostar\" LLC","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}